Integrating RDF data into a relational database system

Details for Australian Patent Application No. 2006236558 (hide)

Owner Oracle International Corporation

Inventors Srinivasan, Jagannathan; Eadon, George; Das, Souripriya; Chong, Eugene Inseok

Agent Spruson & Ferguson

Pub. Number AU-B-2006236558

PCT Pub. Number WO2006/113499

Priority 11/108,204 18.04.05 US

Filing date 14 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 9 June 2011

International Classifications

G06F 17/30 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific functions - Information retrieval

Event Publications

19 June 2008 Section 223 Application Received

  Oracle International Corporation An application to extend the time from 18 Nov 2007 to 18 Mar 2008 in which to enter the National Phase has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

7 August 2008 Section 223 Application Allowed

  Oracle International Corporation The time in which to enter the National Phase has been extended to 18 Mar 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

21 August 2008 PCT application entered the National Phase

  PCT publication WO2006/113499 Priority application(s): WO2006/113499

9 June 2011 Application Accepted

  Published as AU-B-2006236558

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236559-Self conforming screen

2006236557-2-amino-quinazolin-5-ones as HSP90 inhibitors useful in treating proliferation diseases